Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03977402 · ClinicalTrials.gov registry record
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
A clinical trial of Cancer and Cancer Risk, sponsored by New Mexico Cancer Research Alliance.
- Recruiting
- Registry status
- 47,500
- Enrollment target
- 1
- Study location
NCT03977402 is a study of Cancer and Cancer Risk that is actively recruiting participants, run by New Mexico Cancer Research Alliance. The registered enrollment target is 47,500 participants, above the 3,414-participant average among 615 other Cancer trials with a reported enrollment target (1291% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03977402, a study of Cancer and Cancer Risk, is actively recruiting participants, sponsored by New Mexico Cancer Research Alliance.
- RECRUITING
- Registry status
- 47,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
Conditions Studied
Interventions
- OTHER Biological specimen collection
Study Locations (1)
New Mexico
- University of New Mexico Comprehensive Cancer Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47,500 participants |
| Start Date | 2016-01-27 |
| Est. Completion | 2037-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03977402
The ClinicalTrials.gov registry entry for NCT03977402 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 47,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,414-participant average among 615 other Cancer trials with a reported enrollment target (1291% higher). The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Biological specimen collection is the first listed.
NCT03977402 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT03977402 about?
NCT03977402 is a clinical study titled "Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer". The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the ...
What is the current status of trial NCT03977402?
This trial is currently recruiting. The enrollment target is 47,500 participants. The study started on 2016-01-27. Estimated completion is 2037-12-31.
What conditions does trial NCT03977402 study?
This clinical trial studies the following conditions: Cancer, Cancer Risk.
What interventions are being tested in trial NCT03977402?
The interventions under investigation include: Biological specimen collection (OTHER).
Who is sponsoring clinical trial NCT03977402?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03977402 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.